Xiaoyun Shen

Xiaoyun Shen

Auto-generated profile, based on publicly available information

Xiaoyun Shen

Key Laboratory of Endoscopic Technology Research, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2014 in The FEBS Journal
Verified
Journal Article
Closed access
PDF file
XHXin‐Ping Huang
Xin‐Ping Huang
JHJin Hou
Jin Hou
XSXiao‐Yun Shen
Xiao‐Yun Shen
CHChao‐Yuan Huang
Chao‐Yuan Huang
XZXue‐Hui Zhang
Xue‐Hui Zhang
XLXiao‐Ling Luo
Xiao‐Ling Luo

Verified
Journal Article
Open access
PDF file
YCYuhan Chen
Yuhan Chen
ZZZhaochong Zheng
Zhaochong Zheng
XSXiaoyun Shen
Xiaoyun Shen
ZWZhifeng Wu
Zhifeng Wu
YDYinying Dong
Yinying Dong
JCJason Chia-Hsien Cheng
Jason Chia-Hsien Cheng
Lipopolysaccharide (LPS)/toll-like receptor 4 (TLR4) signaling pathway is demonstrated to be involved in the hepatic fibrosis. MicroRNA (miR)-146a-5p is a key regulator of the innate immune response. The functional significance of miR-146a-5p during the LPS/TLR4 mediated hepatic fibrosis process remains unclear. In this study, we found that TLR4 and α-smooth muscle actin (α-SMA) were up-regulated and miR-146a-5p was down-regulated in human hepatic stellate cell (HSC) line LX2 after LPS stimulation. Overexpression of miR-146a-5p inhibited LPS induced pro-inflammatory cytokines secretion through down-regulating the expression levels of TLR-4, IL-1 receptor-associated kinase 1 (IRAK1), TNF receptor associated factor-6 (TRAF6) and phosphorylation of nuclear factor-kappa B (NF-κB). Knockdown of IRAK1 and TRAF6 also suppressed pro-inflammatory cytokine production by inhibiting NF-κB phosphorylation. In addition, miR-146a-5p mimic blocked LPS induced TRAF6 dependent c-Jun N-terminal kinase (JNK) and Smad2 activation as well as α-SMA production. Taken together, these results suggest that miR-146a-5p suppresses pro-inflammatory cytokine secretion and cell activation of HSC through inhibition of TLR4/NF-κB and TLR4/TRAF6/JNK pathway.

8 January 2014 in International Journal of Oncology
Verified
Journal Article
Closed access
PDF file
XSXiaoyun Shen
Xiaoyun Shen
YZYong Zhang
Yong Zhang
YFYan Feng
Yan Feng
LZLitu Zhang
Litu Zhang
JLJilin Li
Jilin Li
XLXiaoling Luo
Xiaoling Luo
Epigallocatechin-3-gallate (EGCG) has been shown to inhibit the growth and induce apoptosis of certain cancer cells. The aim of this study was to determine the role of EGCG in hepatocellular carcinoma (HCC) and the underlying mechanism(s) thereof. MTT assay was used to determine the cell growth inhibition by EGCG. Apoptosis induced by EGCG was investigated by both AO/EB staining and flow cytometry. The cell cycle distribution was analyzed by flow cytometry. The mRNA levels of the AKT pathway were analyzed by quantitative PCR. The expression of AKT and its phosphorylation at Ser473 were detected by western blotting. The IC50 of EGCG at 48 h for HepG2, SMMC7721 and SK-hep1 cells were 74.7, 59.6 and 61.3 µg/ml, respectively. Significantly higher proportion of SMMC7721 cells entered the S phase upon treatment with EGCG for 48 h compared with control cells. EGCG decreased the mRNA levels of PI3K, AKT and NF-κB. The protein levels of AKT decreased and its phosphorylation at Ser473 was downregulated with EGCG treatment. EGCG inhibited growth by affecting the cell cycle and induced apoptosis in different HCC cells by downregulating PI3K/AKT activity. The results suggest the potential of EGCG as an anticancer agent in the prevention or treatment of HCC.

1 May 2018 in Cancer Letters
Verified
Journal Article
Closed access
YDYinying Dong
Yinying Dong
ZWZhifeng Wu
Zhifeng Wu
MHMingyan He
Mingyan He
YCYuhan Chen
Yuhan Chen
YCYixing Chen
Yixing Chen
ZZZhaochong Zheng
Zhaochong Zheng

3 February 2015 in International Journal of Oncology
Verified
Journal Article
Open access
PDF file
JWJiangyan Wang
Jiangyan Wang
YXYu’an Xie
Yu’an Xie
YFYan Feng
Yan Feng
LZLitu Zhang
Litu Zhang
XHXinping Huang
Xinping Huang
XLXiaoling Luo
Xiaoling Luo
(-)-Epigallocatechingallate (EGCG) as a representative polyphenol has attracted increasing attention due to its diversified effects, especially its potential as an agent for the prevention or treatment of certain cancers. However, the molecular mechanisms of EGCG-induced apoptosis in B lymphoma cells are unclear. The aim of this study was to investigate the effect of EGCG on proliferation and apoptosis in the B lymphoma cell lines Jeko-1 and Raji, and determine the underlying mechanisms. Cell proliferation and cytotoxicity were determined by the cell counting kit (CCK-8) assay; apoptosis was assessed by flow cytometry using the Annexin V-PE/7AAD double staining; Fas, Bcl-2 and Bax mRNA expression levels were determined by real-time PCR; caspase activity was measured by the caspase activity assay kit; the expression levels of apoptosis-associated proteins were determined by western blot analysis. We demonstrated that EGCG induced growth inhibition and apoptosis in a dose- and time-dependent manner. In agreement, EGCG upregulated the mRNA expression of Fas and Bax while downregulating Bcl-2. Protein expression levels of Bax, activated caspase-3, -7, -8, and -9, and PARP were increased, while Bcl-2 protein levels were reduced by EGCG treatment. Taken together, EGCG induces B lymphoma cell apoptosis by triggering caspase-dependent intrinsic (mitochondrial) and extrinsic (death receptor) pathways. These findings suggest that EGCG may be a potential agent for the treatment of B lymphoma.

1 April 2009 in Cellular & Molecular Immunology
Verified
Journal Article
Open access
PDF file
HFHong Fu
Hong Fu
SSShaohua Song
Shaohua Song
FLFang Liu
Fang Liu
ZNZhijia Ni
Zhijia Ni
YTYi Tang
Yi Tang
QWQuanxing Wang
Quanxing Wang
SOCS1 is a key regulator of cytokine signaling and is important for maintaining balance in the immune system. It is thought to participate in negative feedback loops in cytokine signaling and may be an important signal for the regulation of dendritic cell (DC) maturation. However, it remains unclear whether DCs transduced with SOCS1 exhibit characteristics of regulatory DCs and induce allogeneic T-cell hyporesponsiveness. In this study, we constructed adenoviral vector coding SOCS1 (Ad-SOCS1) that can efficiently increase SOCS1 gene expression in bone marrow-derived dendritic cells. DCs transduced with Ad-SOCS1 (DC-SOCS1) expressed low levels of costimulatory and MHC molecules, were resistant to maturation and activation stimulation, induced allogeneic T-cell hyporesponsiveness, and promoted the generation of regulatory-like T cells in vitro. DC-SOCS1 pretreatment significantly prolonged the survival of allografts and led to a substantial increase in the generation of regulatory T cells. Our data suggest that SOCS1 inhibits DC maturation and induces regulatory DC generation, therefore possessing therapeutic potential to prevent rejection in organ transplantation.